Hypothesis
Incorporating tissue‑specific metabolic state variables (AMPK activity, mTORC1 signaling, cytosolic acetyl‑CoA concentration) as dynamic node features in graph neural networks will significantly improve the prediction of autophagy‑modulating drug efficacy across aged tissues, whereas models that ignore these variables will systematically overestimate benefit in metabolically stressed organs such as liver and underestimate it in reserve tissues like skeletal muscle.
Mechanistic Basis
Autophagy functions as a rationing system that is toggled by the cell’s perception of siege conditions. Nutrient‑sensing kinases (AMPK, mTOR) and metabolite sensors (acetyl‑CoA) directly gate the transcriptional and post‑translational control of core autophagy genes (e.g., BECN1, LC3) [4, 5]. In aged cells, chronic elevation of acetyl‑CoA suppresses Atg gene expression, while AMPK activation can override this block [5]. Consequently, the same drug that stimulates autophagy initiation may be futile in a tissue with high acetyl‑CoA/low AMPK (e.g., aged liver) but protective where AMPK dominates (e.g., aged muscle). Current GNN architectures for drug‑target interaction predict binding affinity in a static topological context and lack any representation of these metabolic switches [1, 2].





























